nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cardiovascular risks: New insights from Framingham
|
Levy, Daniel |
|
1988 |
116 |
1P2 |
p. 266-272 7 p. |
artikel |
2 |
Central nervous system considerations in the use of β-blockers, angiotensin-converting enzyme inhibitors, and thiazide diuretics in managing essential hypertension
|
Gengo, F.M. |
|
1988 |
116 |
1P2 |
p. 305-310 6 p. |
artikel |
3 |
Effects of stress and the sympathetic nervous system on coronary artery atherosclerosis in the cynomolgus macaque
|
Manuck, Stephen B. |
|
1988 |
116 |
1P2 |
p. 328-333 6 p. |
artikel |
4 |
Future implications
|
Chobanian, Aram |
|
1988 |
116 |
1P2 |
p. 347-349 3 p. |
artikel |
5 |
Impact of β-blockade on complex cognitive functioning
|
Streufert, Siegfried |
|
1988 |
116 |
1P2 |
p. 311-315 5 p. |
artikel |
6 |
Introduction
|
Julius, Stevo |
|
1988 |
116 |
1P2 |
p. 265-266 2 p. |
artikel |
7 |
Left ventricular hypertrophy: Its prime importance as a controllable risk factor
|
Weber, Jan R. |
|
1988 |
116 |
1P2 |
p. 272-279 8 p. |
artikel |
8 |
New concepts in the treatment of elderly hypertensive patients
|
Wikstrand, John |
|
1988 |
116 |
1P2 |
p. 296-300 5 p. |
artikel |
9 |
Overview: Hypertension and atherosclerosis
|
Chobanian, Aram |
|
1988 |
116 |
1P2 |
p. 319-322 4 p. |
artikel |
10 |
Panel discussion: Part I
|
Julius, Stevo |
|
1988 |
116 |
1P2 |
p. 315-318 4 p. |
artikel |
11 |
Panel discussion: Part II
|
Chobanian, Aram |
|
1988 |
116 |
1P2 |
p. 349-354 6 p. |
artikel |
12 |
Pathophysiologic and pharmacotherapy considerations in the management of the black hypertensive patient
|
Cook, Charles A. |
|
1988 |
116 |
1P2 |
p. 288-295 8 p. |
artikel |
13 |
Primary prevention in patients with hypertension: Comments on the clinical implications of the MAPHY Study
|
Wikstrand, John |
|
1988 |
116 |
1P2 |
p. 338-347 10 p. |
artikel |
14 |
The hypertensive patient with concomitant cardiovascular disease
|
Tifft, Charles P. |
|
1988 |
116 |
1P2 |
p. 280-287 8 p. |
artikel |
15 |
The role of sympathetic activity in atherogenesis: Effects of β-blockade
|
Ablad, Bengt |
|
1988 |
116 |
1P2 |
p. 322-327 6 p. |
artikel |
16 |
The Safety After Fifty Evaluation trial: Evaluation of the safety and efficacy of antihypertensive therapy with metoprolol in patients 50 to 75 years of age: Study design
|
Rich, Michael W. |
|
1988 |
116 |
1P2 |
p. 301-304 4 p. |
artikel |
17 |
Thromboatherosclerotic complications in hypertensives: Results of the Stockholm Metoprolol (secondary prevention) Trial
|
Olsson, Gunnar |
|
1988 |
116 |
1P2 |
p. 334-338 5 p. |
artikel |